Calyxt Identifies More Than 15,000 Unique Chemical Signatures in Lab-Scale BioFactory(TM) Production Run

Stock Information for Calyxt Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Calyxt Inc.

Calyxt Announces Stockholder Approval of Merger With Cibus
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update
Calyxt Completes One-for-Ten Reverse Stock Split
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
Calyxt Announces Effective Date of Reverse Stock Split
CALYXT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Calyxt, Inc. - CLXT
Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update
Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.